12.14
+0.385(+3.28%)
Currency In USD
Previous Close | 11.75 |
Open | 11.92 |
Day High | 12.21 |
Day Low | 11.85 |
52-Week High | 12.35 |
52-Week Low | 5.79 |
Volume | 570,324 |
Average Volume | 2.28M |
Market Cap | 1.93B |
PE | -11.03 |
EPS | -1.1 |
Moving Average 50 Days | 9.39 |
Moving Average 200 Days | 8.67 |
Change | 0.39 |
If you invested $1000 in Ocular Therapeutix, Inc. (OCUL) 10 years ago, it would be worth $513.32 as of July 30, 2025 at a share price of $12.135. Whereas If you bought $1000 worth of Ocular Therapeutix, Inc. (OCUL) shares 5 years ago, it would be worth $1,496.3 as of July 30, 2025 at a share price of $12.135.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ocular Therapeutix™ to Report Second Quarter 2025 Financial Results on August 5, 2025
GlobeNewswire Inc.
Yesterday at 11:00 AM GMT
BEDFORD, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it plans to host a conference call and webcast on T
Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences
GlobeNewswire Inc.
Jul 22, 2025 11:00 AM GMT
BEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming scientific conferences
Ocular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused Company
GlobeNewswire Inc.
Jun 26, 2025 5:54 PM GMT
The new branding showcases the Company's innovative vision for the future and mission to redefine the retina experienceBEDFORD, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company